Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort

Nicolas Martinez-Calle,  Amy A. Kirkwood,  Maxine Lamb,  Alex Smith,  Jahanzaib Khwaja,  Kate Manos,  Caroline Shrubsole,  Nicola Gray,  Katharine Lewis,  Ann Tivey,  Mark J. Bishton,  Eliza Hawkes,  Matthew J. Ahearne,  Wendy Osborne,  Graham P. Collins,  Timothy Illidge,  Kim M. Linton,  Kate Cwynarski,  Cathy Burton,  Christopher P. Fox.

Advances in Therapy
Volume: 38, Pages: 3789-3802.

Frontline management of nodular lymphocyte predominant Hodgkin lymphoma – a retrospective UK multicentre study

Matthew R. Wilson,  Timothy Bagguley,  Alexandra Smith,  Eve Roman,  Russell Patmore,  Katharine Hanlon,  Mike Leach,  Mark Bishton,  Cathy Burton,  Pam McKay.

British Journal of Haematology
Volume: 186, Issue: 6, Pages: 214-217.

Receiving treatment at a specialist centre confers an overall survival benefit for patients with mantle cell lymphoma

Rory McCulloch,  Alexandra Smith,  Nicola Crosbie,  Russell Patmore,  Simon Rule.

British Journal of Haematology
Volume: 185, Issue: 5, Pages: 1002-1004.

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)

Alexandra Smith,  Eve Roman,  Simon Appleton,  Debra Howell,  Rod Johnson,  Cathy Burton,  Russell Patmore.

British Journal of Haematology
Volume: 181, Issue: 2, Pages: 215-228.

Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort

A. G. Smith,  D. Painter,  D. A. Howell,  P. Evans,  G. Smith,  R. Patmore,  A. Jack,  E. Roman.

BMJ open
Volume: 4, Issue: 1, Pages: e004266.